AUPH · Aurinia Pharmaceuticals Inc.
Market Cap
$2.17B
Shares
133.05M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-02-26 | Fourth Quarter and Full Year 2025 Financial Results Conference Call | Earnings call |
| 2025-11-04 | Third Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-07-31 | Second Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-06-30 | Conference Call to Discuss Positive Results from Phase 1 Study of Aritinercept (AUR200) | Earnings call |
| 2025-05-21 | LUPUS 2025, the 16th International Congress on SLE | Webcast |
Key facts
CIK
1600620
CUSIP
05156V102
13F (30d)
223 filings
222 filers
Visit website
Investor relations